11:34 AM EST - Knight Therapeutics Inc. : Announced the signing of an exclusive license agreement with AstraZeneca, for the rights to Movantik (naloxegol) in Canada and Israel. The financial terms of the agreement were not disclosed. Knight Therapeutics Inc.
shares T.GUD are trading up $0.09 at $10.01.
